-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Valosin-containing protein (VCP) is a AAA+ (ATPase associated with multiple cellular activities) ubiquitous protein involved in protein degradation and cellular homology regulation by the ubiquitin-proteasome system
The IBMPFD nomenclature is defective, and VCP mutations impair autophagy and endocytic transport and increase ATPase activity due to structural changes
This is an international descriptive retrospective study that collected data from routine clinical care visits in patients with MSP
Time to development of signs/symptoms from disease onset
The study included 255 patients (70.
Sign/symptom frequency between the two most common variants
In 2004, six missense pathogenic variants were identified in patients with the triad of myopathy, PDB, and FTD, and the VCP gene was found to be the cause of IBMPFD
After a mean follow-up of 5.
This study extends knowledge about the phenotypic manifestations, natural history, genotype-phenotype correlations, and risk factors for disease progression of VCP disease and contributes to improved care for patients with this complex disease
original provenance